A recent study suggests that people who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional lifestyle plans.
Published data in a prominent medical journal shows that while obese people often shed about a fifth of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing these treatments need to be informed of the danger of rapid weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.
That rate of regain implies a reversion to original mass within about 18 months.
Comparing Approaches
The analysis, which looked at dozens of studies involving thousands of participants, contrasted the results of these new drugs with other pills.
Researchers note that individuals who shed pounds through diet and exercise typically see a less rapid creep back—around 0.1 kg a month—once they finish.
The Reason for the Fast Regain
Nutrition scientists suggest the way of the drugs accounts for the heightened rebound.
These medications copy a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations far above than normal might result in the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication means appetite is uncontrolled, making excessive eating a significant risk."
An Ongoing Issue?
The NHS recommend the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, given the likelihood of relapse, the therapy is often life-long.
This perspective is echoed by pharmaceutical companies, who state that the findings "emphasize the long-term nature of obesity," similar to managing conditions like high blood pressure.
User Accounts
Users who have discontinued the medication explain a intense resurgence of cravings.
"It felt as if a trigger flipping and you're instantly extremely hungry," said a patient.
The struggle is compounded if patients have not developed lasting lifestyle or habit modifications during therapy.
Significant Use
Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Use is greater among women than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are powerful agents for weight loss, they are not a magic fix and long-term success relies on integrated lifestyle changes.
